Pappas Ventures
Description
Pappas Ventures is a well-established venture capital firm based in Durham, North Carolina, with a dedicated focus on the life sciences sector. Since its inception, the firm has specialized in identifying and nurturing innovative companies across biotechnology, pharmaceuticals, medical devices, diagnostics, and related health technology fields. Pappas Ventures emphasizes a hands-on approach, often taking active board roles to guide portfolio companies through critical development stages, from early-stage research and development to commercialization.
The firm's investment strategy is characterized by its deep industry expertise and a long-term perspective, aiming to build significant value in its portfolio companies. They typically invest in both private and public life science companies, participating in various funding rounds from seed to growth equity. Pappas Ventures seeks out opportunities with strong scientific foundations, compelling intellectual property, and experienced management teams capable of executing on ambitious growth plans within the complex life sciences landscape.
Pappas Ventures has a substantial track record, managing over $600 million in capital across five venture capital funds. This significant capital base allows them to make meaningful initial investments and provide follow-on funding to support their portfolio companies' continued growth and milestones. Their successful exits include companies that have been acquired by major pharmaceutical and biotech players, underscoring their ability to identify and scale promising ventures within the highly competitive life sciences industry.
Investor Profile
Pappas Ventures has backed more than 51 startups, with 0 new investments in the last 12 months alone. The firm has led 4 rounds, about 8% of its total and boasts 24 exits across its portfolio.
Investment Focus Highlights
- Concentrates on Series B, Series A, Series C rounds (top funding stages).
- Majority of deals are located in United States, Canada.
- Strong thematic focus on Biotechnology, Health Care, Pharmaceutical.
- Typical check size: $3M – $20M.
Stage Focus
- Series B (25%)
- Series A (25%)
- Series C (16%)
- Series Unknown (14%)
- Series D (10%)
- Private Equity (4%)
- Series F (4%)
- Post Ipo Equity (2%)
Country Focus
- United States (90%)
- Canada (8%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Therapeutics
- Medical Device
- Medical
- Biopharma
- Health Diagnostics
- Genetics
- Life Science
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
